Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections...

Ads by GoogleLatest Energy ResearchRenewable energy and climate change report from the IPCC. www.cambridge.org/renewable A generic photo of...

Amylin Pharmaceutical (AMLN) investors got some long-awaited good news Friday afternoon, as the FDA finally granted approval to market Bydureon, an...

Amylin Pharmaceuticals, Inc. and Alkermes plc today announced that the U.S. Food and Drug Administration (FDA) has approved Bydureon (exenatide ...

Tweet Inlyta (axitinib) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma in people who haven't...

1-800-Get-Thin under scrutiny by federal and local officials. advertisement Insurance giant Aetna has joined distressed families and skeptical...

The U.S. Food and Drug Administration said on Friday it had detained shipments of orange juice and concentrate from Brazil and Canada after finding ...

1 create a portfolio now:. XAddAlkermes PLC (ALKS) XAddAmylin Pharmaceuticals Inc. (AMLN) Add . Create Portfolio or Cancel Already have a ...

415,297 shares of Uroplasty Inc (UPI) traded hands on Friday, a 175.72% increase in volume compared to its 20-day average. The stock last traded at...

WASHINGTON — The New England Journal of Medicine on Thursday published an opinion online that called for more rulemaking to govern dietary...